VISION™ Reduces Clinical Timelines for Pivotal Aratana Study

AUSTIN, TX – February 9, 2015 – Aratana Therapeutics, Inc. (PETX) announced on December 18th the positive, statistically-significant (p < 0.05) results from its pivotal field study of AT-001 (Grapiprant), the company’s innovative drug for treating pain...

Case Study: Great Ape Heart Project Database

Background Since the early 1990s, CVD has been a growing concern for caregivers of great apes and, given the limitations described above, inspired the Great Ape Heart Project (GAHP) with a goal to improve the health and welfare of captive great apes and reduce...